AmerisourceBergen 2011 Annual Report Download - page 8

Download and view the complete annual report

Please find page 8 of the 2011 AmerisourceBergen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 24

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24

6
AmerisourceBergen offers
value-added programs and services
to help our customers improve
the efficiency of their pharmacy
operations and improve patient lives.
providers and manufacturers are adequately
reimbursed for the services they provide and the
pharmaceuticals they dispense. In order to meet those
challenges, we have continued to invest in our existing
distribution network and portfolio of value-added
services.We have dramatically increased the productivity
of our distribution network over the last ten years,
and those improvements have led to greater efficiency
and value for our customers.
AmerisourceBergen Drug Corporation (ABDC)
serves community retail and specialty pharmacies,
hospitals and various types of alternate site healthcare
providers with branded, generic, biotech and other
specialty pharmaceuticals as well as over-the-counter
remedies, home healthcare products, and health and
beauty aids.ABDC has 26 distribution centers across
the U.S., and 8 in Canada for a total of 5 million square
feet, supporting approximately 20,000 deliveries to
customers per day. Over the last two years, we have
been implementing a new SAP enterprise resource
planning system which has consolidated our back
office operations for ABDC, and has significantly
improved our ability to interact with our customers.
In 2011, we launched ABC
PassportTM, an integrated
procurement platform for
all customer interactions
with ABDC, which
streamlines order entry,
gives our customers robust
reporting functionality,
and is entirely web-based,
reducing maintenance and
technology support issues.
The goal of our
technology enhancements
is to make it even easier
to do business with AmerisourceBergen, and to use
the data generated from these enhancements to continue
to expand and improve our product and service offerings
for our customers and suppliers. One example of
using enhanced data to drive value for customers is in
improvements we have made in our generics programs,
including our PRxO Generics®Solutions program.
As generics become more and more important to
our customers and suppliers alike, it is essential that
we provide innovative tools and services to help all of
our stakeholders benefit from the growth in generics.
We drive value by establishing customized portfolios
for specific types of healthcare providers, by focusing
on contract compliance, by ensuring new generics are
available as soon as they are approved and launched,
and by using all of our resources to ensure the quickest,
most efficient distribution to the market as possible.
Over the last year, we have focused on collaborating
across all AmerisourceBergen business units to drive
value and innovation for our customers and suppliers.
In addition to supporting our customers as they prepare
for the wave of generic conversions expected in 2012
and beyond, we strive to ensure that our programs
help them continue to meet the needs of a changing
marketplace. A key example of that strategy lies in
our approach to support our community pharmacy
customers as they seek ways to better serve the
expanding base of patients who require specialty
pharmaceuticals.We have combined the expertise we
have in AmerisourceBergen Specialty Group (ABSG)
with the offerings we provide through our Good
Neighbor Pharmacy®Provider Network (GNPPN)
to assist community pharmacists in attracting new
patients, improving retention and patient adherence to
complex therapies, and driving down operating costs.
Our GNPPN network of independently-owned
community pharmacies consists of over 4,600 members,
We provide health systems with
just-in-time delivery of all of the
pharmaceuticals they need to
treat patients, from oral tablets
to advanced injectible therapies.
continued
continued from previous page